共 78 条
[1]
Julka PK(2006)A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma Hepatobiliary Pancreat Dis Int 5 110-114
[2]
Puri T(2011)Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 29 1678-1685
[3]
Rath GK(2012)Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer Invest New Drugs 30 772-778
[4]
Dueñas-González A(2011)Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin’s lymphoma–EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54) Eur J Haematol 86 111-116
[5]
Zarbá JJ(2001)Treatment of classical Kaposi’s sarcoma with gemcitabine Dermatology 202 119-122
[6]
Patel F(1997)Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403-2413
[7]
Madajewicz S(1996)A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer Ann Oncol 7 347-353
[8]
Waterhouse DM(2002)Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer J Clin Oncol 20 160-164
[9]
Ritch PS(1999)Gemcitabine transport in J Natl Cancer Inst 91 1876-1881
[10]
Aurer I(1988) oocytes expressing recombinant plasma membrane mammalian nucleoside transporters Cancer Res 48 4024-4031